PDFAITools
Tempus AI
AI healthcare company using clinical and molecular data to help physicians make data-driven personalized cancer treatment decisions.
What is Tempus AI?
AI for Personalized Cancer Care
Tempus AI is a healthcare technology company that uses artificial intelligence to help physicians make more precise, data-driven treatment decisions for cancer patients. By integrating clinical data, genomic sequencing, and molecular profiling into AI-powered insights, Tempus enables oncologists to match patients to the treatments most likely to benefit them — the promise of precision medicine realized at scale.
The Tempus Data Platform
Tempus has built one of the world's largest libraries of de-identified clinical and molecular data from real-world cancer patients. Its AI models trained on this dataset can identify molecular patterns that correlate with treatment response, help match patients to relevant clinical trials, and generate insights from pathology images that support diagnostic accuracy. The platform integrates into clinical workflows through its physician-facing application.
- Genomic and molecular testing and analysis
- AI-powered treatment matching using real-world evidence
- Clinical trial matching based on molecular and clinical profiles
- AI pathology analysis for diagnostic support
- Real-world data platform for pharmaceutical research
Impact on Oncology Practice
Thousands of oncologists at major cancer centers use Tempus to access genomic testing, get AI-generated treatment insights, and identify clinical trial options for their patients. For pharmaceutical and biotech companies, Tempus's real-world data platform provides insights to support drug development and market understanding in oncology.
Key Features
Comprehensive genomic sequencing of tumor tissue to identify actionable alterations.
Matches patients to evidence-based therapies using molecular and clinical data.
Analyzes pathology images with AI to support more accurate diagnostic interpretation.
Identifies relevant clinical trials based on each patient's unique molecular profile.
Large-scale de-identified dataset powers research for pharmaceutical companies.
Who Uses Tempus AI?
Cancer physicians get AI-powered treatment recommendations based on genomic findings.
Match patients to open trials they would not otherwise be identified for.
Drug companies use Tempus data to understand real-world treatment patterns and outcomes.
Institutions track outcomes and quality metrics across their oncology patient population.
Pros & Cons
✅ Pros
- One of the largest real-world oncology datasets used to train AI models
- Integrates genomics, pathology, and clinical data for comprehensive insights
- Clinical trial matching helps patients access cutting-edge treatments
- Trusted by oncologists at leading cancer centers nationwide
- Supports both clinical care and pharmaceutical research use cases
❌ Cons
- Focused exclusively on oncology — not applicable to other therapeutic areas
- Genomic testing costs and insurance coverage can be barriers for some patients
- AI recommendations still require physician interpretation and clinical judgment
Tempus AI Pricing
Genomic Testing
- Comprehensive tumor sequencing
- AI treatment insights
- Trial matching
- Physician portal
Pharma Research
- Real-world data access
- Custom analytics
- Research collaboration
- De-identified datasets
Tempus AI earns a 4.8/5 rating from our editorial team. While it requires a paid subscription, the professional-grade capabilities deliver strong ROI for serious users. Standout strengths include one of the largest real-world oncology datasets used to train ai models and integrates genomics, pathology, and clinical data for comprehensive insights.
Get Started with Tempus AI →